Silver Book

Silver Book Fact

Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs therapies; looking for the cause of the disease and continuing to search for environmental and genetic factors; and working to develop new protective drugs that can delay, reverse, or even prevent the disease.

National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH. Parkinson’s Disease Information Page; 2007. http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm

Reference

Title
Parkinson’s Disease Information Page
Publication Date
2007
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The present value QUALY gains associated with a new drug that by 2010 could delay disease onset by 1, 3, and 5 years. The dollar value estimates range from approximately…  
  • “A treatment breakthrough that delayed the age of onset of Alzheimer’s disease by five years and began to show its effects in 2015 would decrease the total number of Americans…  
  • One study found that dopaminergenic therapies for Parkinson’s disease patients resulted in lower dyskinesias as well as lower incidences of freezing, drowsiness, and edema–resulting in better quality-of-life through symptom control.  
  • An Alzheimer’s treatment breakthrough that slowed disease progression and began to show effects in 2015, would reduce Medicaid costs for people with the disease by $62 billion–from the expected $178…  
  • According to the Pharmaceutical Research and Manufacturers of America, because of medical research, the number of Americans with Alzheimer’s could decrease by 3 million in 2025.